• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[区域隔离灌注:也适用于老年患者]

[Regional isolated perfusion: also applicable in elderly patients].

作者信息

Noorda E M, Vrouenraets B C, Nieweg O E, Kroon B B R

机构信息

Nederlands Kanker Instituut/Antoni van Leeuwenhoek Ziekenhuis, afd. Chirurgische Oncologie, Plesmanlaan 121, 1066 CX Amsterdam.

出版信息

Ned Tijdschr Geneeskd. 2003 Mar 22;147(12):529-33.

PMID:12693077
Abstract

In 3 patients over 75 years of age with a malignancy, limb salvage was achieved through the application of isolated limb perfusion with melphalan with or without tumour necrosis factor alpha: an 82-year-old woman with extensive locoregional melanoma metastases on her lower leg, a 78-year-old woman with a large, ulcerating recurrence of melanoma on her lower leg and an 83-year-old woman with recurrent sarcoma of the lower arm. There were no complications and the women recovered well. Isolated limb perfusion can be effectively and safely used in older patients with irresectable tumours of the extremities, offering them limb salvage for the remainder of their lives.

摘要

在3例75岁以上患有恶性肿瘤的患者中,通过应用美法仑单独肢体灌注(伴或不伴肿瘤坏死因子α)实现了保肢:一名82岁女性小腿部有广泛的局部区域黑色素瘤转移,一名78岁女性小腿部有黑色素瘤的巨大溃疡性复发,一名83岁女性有下臂复发性肉瘤。没有出现并发症,这些女性恢复良好。单独肢体灌注可有效且安全地用于患有不可切除的四肢肿瘤的老年患者,为他们提供余生的肢体保全。

相似文献

1
[Regional isolated perfusion: also applicable in elderly patients].[区域隔离灌注:也适用于老年患者]
Ned Tijdschr Geneeskd. 2003 Mar 22;147(12):529-33.
2
Repeat isolated limb perfusion with TNFalpha and melphalan for recurrent limb melanoma after failure of previous perfusion.在先前灌注失败后,对复发性肢体黑色素瘤重复使用肿瘤坏死因子α和马法兰进行孤立肢体灌注。
Eur J Surg Oncol. 2006 Apr;32(3):318-24. doi: 10.1016/j.ejso.2005.10.009. Epub 2006 Jan 18.
3
Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor-alpha and melphalan for limb-threatening soft tissue sarcoma.217例连续应用肿瘤坏死因子-α和美法仑进行孤立肢体灌注治疗肢体威胁性软组织肉瘤的疗效及预后因素分析
Cancer. 2006 Apr 15;106(8):1776-84. doi: 10.1002/cncr.21802.
4
Isolated limb perfusion with tumour necrosis factor-alpha and melphalan for unresectable bone sarcomas of the lower extremity.采用肿瘤坏死因子-α和美法仑进行隔离肢体灌注治疗下肢不可切除骨肉瘤。
Eur J Surg Oncol. 1999 Oct;25(5):509-14. doi: 10.1053/ejso.1999.0687.
5
Isolated limb perfusions with tumor necrosis factor and melphalan for locally recurrent soft tissue sarcoma in previously irradiated limbs.在先前接受过放疗的肢体中,使用肿瘤坏死因子和美法仑进行孤立肢体灌注治疗局部复发性软组织肉瘤。
Ann Surg Oncol. 2005 May;12(5):406-11. doi: 10.1245/ASO.2005.03.093. Epub 2005 Mar 31.
6
Isolated limb perfusion for unresectable melanoma of the extremities.肢体孤立灌注治疗四肢不可切除的黑色素瘤。
Arch Surg. 2004 Nov;139(11):1237-42. doi: 10.1001/archsurg.139.11.1237.
7
Isolated limb perfusion with melphalan and tumor necrosis factor alpha for advanced melanoma and soft-tissue sarcoma.使用美法仑和肿瘤坏死因子α进行隔离肢体灌注治疗晚期黑色素瘤和软组织肉瘤。
Ann Surg Oncol. 2007 Jan;14(1):230-8. doi: 10.1245/s10434-006-9040-x.
8
[Tumor necrosis factor α and melfalan-based hyperthermic isolated limb perfusion in locally advanced extremity soft tissue sarcomas and melanomas].[肿瘤坏死因子α与基于美法仑的高温隔离肢体灌注治疗局部晚期肢体软组织肉瘤和黑色素瘤]
Cir Esp. 2012 Feb;90(2):114-20. doi: 10.1016/j.ciresp.2011.10.012. Epub 2012 Jan 5.
9
Isolated limb perfusion with tumor necrosis factor and melphalan for non-resectable soft tissue sarcomas: long-term results on efficacy and limb salvage in a selected group of patients.使用肿瘤坏死因子和美法仑进行隔离肢体灌注治疗不可切除的软组织肉瘤:一组特定患者的长期疗效和肢体挽救结果
J Surg Oncol. 2008 Sep 1;98(3):148-55. doi: 10.1002/jso.21081.
10
Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: the value of adjuvant radiotherapy.肿瘤坏死因子α和美法仑隔离肢体灌注治疗局部晚期软组织肉瘤:辅助放疗的价值
Ann Surg Oncol. 2006 Apr;13(4):518-24. doi: 10.1245/ASO.2006.02.005. Epub 2006 Feb 16.